ASMB Assembly Biosciences, Inc.
Fundamentals / CIK 0001426800 / USDAssembly Biosciences, Inc. reported $72.30M in revenue and a net loss of $11.10M for the fiscal year ended December 31, 2025 (up 153.5% year over year), with a -29.5% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ASMB in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025$72.30M +153.5% YoY
-
Operating Income FY 2025-$21.33M -29.5% margin
-
Net Income FY 2025-$11.10M -15.4% net margin
-
Diluted EPS FY 2025-$0.51 Split-adjusted
-
Free Cash Flow FY 2025-$40.68M -56.3% FCF margin
-
Cash & ST Investments Sep 30, 2026$314.3M Total debt: $2.21M
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $72.30M | $28.52M | $7.16M | $0 | $6.25M | $79.11M | $15.96M | $14.80M | $9.02M | $0 |
| Research & Development | $64.81M | $55.93M | $48.90M | $69.98M | $68.52M | $106.8M | $85.76M | $72.74M | $44.23M | $33.09M |
| Total Operating Expenses | $84.42M | $73.94M | $71.81M | $94.11M | $138.9M | $143.9M | $118.7M | $107.5M | $61.25M | -- |
| Operating Income | -$12.12M | -$45.42M | -$64.65M | -$94.11M | -$132.7M | -$64.78M | -$102.7M | -$92.73M | -$52.23M | -$45.28M |
| EBITDA | -$11.99M | -$45.29M | -$64.20M | -$93.62M | -$132.2M | -$64.08M | -$102.2M | -$92.09M | -$52.01M | -$45.20M |
| Interest Income | $6.00M | $5.57M | $3.45M | $1.02M | $302K | $2.62M | $4.30M | $3.08M | $983K | $1.54M |
| Income Before Tax | -$6.12M | -$39.85M | -$61.20M | -$93.09M | -$132.4M | -$62.15M | -$98.41M | -$89.65M | -$51.86M | -$44.88M |
| Income Tax Expense | $0 | $330K | $33K | $0 | -$2.53M | $0 | -$774K | $1.10M | -$9.05M | -$618K |
| Net Income | -$6.12M | -$40.18M | -$61.23M | -$93.09M | -$129.9M | -$62.15M | -$97.63M | -$90.75M | -$42.81M | -$44.26M |
| Basic EPS | -$0.55 | -$6.69 | -$13.38 | -$23.08 | -$36.01 | -$21.01 | -$44.66 | -$47.78 | -$28.93 | -$30.85 |
| Diluted EPS | -$0.55 | -$6.69 | -$13.38 | -$23.08 | -$36.01 | -$21.01 | -$44.66 | -$47.78 | -$28.93 | -$30.85 |
| Basic Shares Outstanding | 11.2M | 6.0M | 4.6M | 4.0M | 3.6M | 3.0M | 2.2M | 1.9M | 1.5M | 1.4M |
| Diluted Shares Outstanding | 11.2M | 6.0M | 4.6M | 4.0M | 3.6M | 3.0M | 2.2M | 1.9M | 1.5M | 1.4M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.96M | $13.37M | $8.21M | -- | $10.79M | $9.63M | $9.42M | $7.36M |
| Research & Development | $20.23M | $14.92M | $14.90M | $17.25M | $16.59M | $16.12M | $14.85M | $14.28M |
| Total Operating Expenses | $26.37M | $19.72M | $19.58M | $22.67M | $21.67M | $20.72M | $19.36M | $18.89M |
| Operating Income | -$23.41M | -$6.34M | -$11.37M | $19.80M | -$10.88M | -$11.09M | -$9.94M | -$11.53M |
| EBITDA | -$23.39M | -$6.32M | -$11.34M | $19.83M | -$10.85M | -$11.06M | -$9.91M | -$11.50M |
| Interest Income | $3.16M | $2.49M | $2.29M | $2.29M | $1.69M | $895K | $1.12M | $1.12M |
| Income Before Tax | -- | -- | -- | -- | -$9.20M | -$10.20M | -- | -- |
| Income Tax Expense | -- | -- | -- | -- | $0 | $0 | -- | -- |
| Net Income | -$20.26M | -$3.86M | -$9.08M | $22.09M | -$9.20M | -$10.20M | -$8.82M | -$10.34M |
| Basic EPS | -$0.93 | -$0.20 | -$0.54 | -- | -$0.72 | -$1.33 | -$1.17 | -- |
| Diluted EPS | -$0.93 | -$0.20 | -$0.54 | -- | -$0.72 | -$1.33 | -$1.17 | -- |
| Basic Shares Outstanding | 21.8M | 18.9M | 16.9M | -- | 12.7M | 7.7M | 7.5M | -- |
| Diluted Shares Outstanding | 21.8M | 18.9M | 16.9M | -- | 12.7M | 7.7M | 7.5M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $58.45M | $38.34M | $19.84M | $52.42M | $45.63M | $59.44M | $46.73M | $41.47M | $82.03M | $28.57M |
| Short-Term Investments | $189.7M | $73.73M | $110.4M | $39.19M | $101.0M | $157.0M | $227.3M | $176.6M | $37.91M | $24.39M |
| Cash & Short-Term Investments | $248.1M | $112.1M | $130.2M | $91.61M | $146.6M | $216.4M | $274.0M | $218.1M | $119.9M | $52.96M |
| Accounts Receivable, Net | $974K | $0 | $43K | $944K | $336K | $1.23M | $3.37M | $2.43M | $2.27M | $0 |
| Total Current Assets | $254.5M | $115.5M | $133.8M | $96.97M | $154.2M | $224.5M | $282.8M | $222.5M | $123.1M | $53.57M |
| Property, Plant & Equipment, Net | $221K | $284K | $385K | $743K | $1.14M | $1.60M | $1.83M | $557K | $860K | $215K |
| Goodwill | -- | -- | -- | -- | -- | $12.64M | $12.64M | $12.64M | $12.64M | $12.64M |
| Intangible Assets | -- | -- | -- | -- | -- | -- | -- | -- | $29.00M | $29.00M |
| Long-Term Investments | -- | -- | -- | $0 | $27.97M | $0 | $0 | $0 | $3.35M | $2.44M |
| Other Non-Current Assets | $312K | $312K | $312K | $889K | $1.70M | $6.39M | $1.68M | $3.35M | $340K | -- |
| Total Non-Current Assets | $3.04M | $3.67M | $3.04M | $4.83M | $36.86M | $58.76M | $57.13M | $45.54M | $46.19M | $44.54M |
| Total Assets | $257.6M | $119.2M | $136.8M | $101.8M | $191.1M | $283.3M | $339.9M | $268.0M | $169.3M | $98.12M |
| Accounts Payable | $1.17M | $585K | $461K | $2.49M | $2.66M | $4.60M | $1.73M | $3.69M | $2.12M | $2.37M |
| Deferred Revenue (Current) | $36.90M | $37.62M | $30.91M | -- | -- | -- | $6.41M | $5.10M | $45.78M | $0 |
| Total Current Liabilities | $48.78M | $47.80M | $39.23M | $16.30M | $16.07M | $24.43M | $24.44M | $18.47M | $13.49M | $7.12M |
| Deferred Revenue (Non-Current) | $0 | $35.38M | $55.38M | $2.73M | $2.73M | $8.99M | $30.64M | $35.56M | $40.56M | $0 |
| Total Non-Current Liabilities | $2.06M | $38.01M | $56.50M | $2.83M | $6.06M | $18.24M | $42.25M | $38.92M | $42.69M | $11.12M |
| Total Liabilities | $50.84M | $85.81M | $95.73M | $19.13M | $22.13M | $42.68M | $66.69M | $57.39M | $56.18M | $18.24M |
| Total Debt (incl. Leases) | $2.63M | $3.09M | $2.34M | $3.46M | $6.48M | $10.13M | $12.27M | -- | -- | -- |
| Common Stock | $16K | $7.0K | $5.0K | $4.0K | $48K | $34K | $32K | $25K | $20K | $17K |
| Retained Earnings | -$832.0M | -$825.9M | -$785.7M | -$724.5M | -$631.4M | -$501.6M | -$439.4M | -$341.8M | -$251.0M | -$208.2M |
| Accumulated Other Comp. Income | -$41K | -$211K | -$81K | -$803K | -$419K | -$270K | -$201K | -$347K | -$392K | -$601K |
| Total Stockholders' Equity | $206.8M | $33.36M | $41.10M | $82.66M | $168.9M | $240.6M | $273.2M | $210.7M | $113.1M | $79.88M |
| Total Equity | $206.8M | $33.36M | $41.10M | $82.66M | $168.9M | $240.6M | $273.2M | $210.7M | $113.1M | $79.88M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $29.07M | $32.29M | $31.12M | $58.45M | $22.53M | $24.01M | $23.41M | $38.34M |
| Short-Term Investments | $285.2M | $288.1M | $195.5M | $189.7M | $210.0M | $50.97M | $67.61M | $73.73M |
| Cash & Short-Term Investments | $314.3M | $320.4M | $226.6M | $248.1M | $232.6M | $75.00M | $91.03M | $112.1M |
| Accounts Receivable, Net | $582K | $822K | $451K | $974K | $912K | -- | -- | $0 |
| Total Current Assets | $321.2M | $328.0M | $232.6M | $254.5M | $236.8M | $77.47M | $95.53M | $115.5M |
| Property, Plant & Equipment, Net | $291K | $315K | $214K | $221K | $229K | $219K | $251K | $284K |
| Other Non-Current Assets | $1.75M | $312K | $312K | $312K | $312K | $312K | $312K | $312K |
| Total Non-Current Assets | $4.13M | $2.85M | $2.90M | $3.04M | $3.19M | $3.31M | $3.49M | $3.67M |
| Total Assets | $325.3M | $330.8M | $235.5M | $257.6M | $240.0M | $80.78M | $99.02M | $119.2M |
| Accounts Payable | $3.18M | $1.18M | $1.13M | $1.17M | $1.68M | $743K | $875K | $585K |
| Deferred Revenue (Current) | $13.74M | $16.30M | $29.08M | $36.90M | $42.36M | $40.92M | $40.82M | $37.62M |
| Total Current Liabilities | $24.92M | $23.45M | $35.00M | $48.78M | $53.38M | $47.29M | $46.63M | $47.80M |
| Deferred Revenue (Non-Current) | -- | -- | -- | $0 | $1.72M | $13.04M | $22.76M | $35.38M |
| Total Non-Current Liabilities | $1.57M | $1.74M | $1.90M | $2.06M | $3.92M | $15.39M | $25.25M | $38.01M |
| Total Liabilities | $26.49M | $25.18M | $36.90M | $50.84M | $57.30M | $62.68M | $71.88M | $85.81M |
| Total Debt (incl. Leases) | $2.21M | $2.35M | $2.49M | $2.63M | $2.75M | $2.88M | $3.02M | $3.09M |
| Common Stock | $20K | $20K | $16K | $16K | $16K | $8.0K | $8.0K | $7.0K |
| Retained Earnings | -$865.2M | -$845.0M | -$841.1M | -$832.0M | -$854.1M | -$844.9M | -$834.7M | -$825.9M |
| Accumulated Other Comp. Income | -$989K | -$623K | -$368K | -$41K | -$90K | -$279K | -$253K | -$211K |
| Total Stockholders' Equity | $298.8M | $305.6M | $198.6M | $206.8M | $182.7M | $18.10M | $27.13M | $33.36M |
| Total Equity | $298.8M | $305.6M | $198.6M | $206.8M | $182.7M | $18.10M | $27.13M | $33.36M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$6.12M | -$40.18M | -$61.23M | -$93.09M | -$129.9M | -$62.15M | -$97.63M | -$90.75M | -$42.81M | -$44.26M |
| Depreciation & Amortization | $129K | $129K | $450K | $498K | $466K | $691K | $494K | $643K | $219K | $80K |
| Stock-Based Compensation | $4.68M | $3.12M | $5.12M | $6.59M | $5.24M | $21.85M | $20.56M | $28.48M | $8.60M | $5.02M |
| Change in Receivables | -$974K | $43K | $901K | -$608K | $894K | $2.14M | -$944K | -$156K | -$2.27M | $0 |
| Change in Payables | $586K | $124K | -$2.03M | -$166K | -$1.94M | $2.87M | -$1.96M | $1.57M | -$244K | $1.00M |
| Operating Cash Flow | -$41.09M | -$51.12M | $22.74M | -$84.46M | -$93.40M | -$62.96M | -$84.07M | -$64.96M | $1.86M | -$34.88M |
| Capital Expenditure | -$66K | -$28K | -$255K | -$102K | -$3.10M | -$470K | -$1.55M | -$340K | -$865K | -$147K |
| Free Cash Flow | -$41.16M | -$51.15M | $22.49M | -$84.56M | -$96.49M | -$63.43M | -$85.62M | -$65.30M | $995K | -$35.03M |
| Acquisitions, Net | -- | -- | -- | -- | -- | -- | -- | -- | -- | $0 |
| Purchases of Investments | -$229.8M | -$90.50M | -$133.9M | -$27.58M | -$160.4M | -$193.2M | -$281.3M | -$183.9M | -$48.23M | -$7.95M |
| Sales & Maturities of Investments | -- | -- | $65.02M | $116.8M | $187.7M | $263.5M | $232.6M | $48.88M | $33.46M | -- |
| Investing Cash Flow | -$113.5M | $40.17M | -$69.14M | $90.64M | $26.52M | $68.07M | -$50.32M | -$135.4M | -$15.64M | $36.20M |
| Common Stock Issued | $1.92M | $2.03M | $4.55M | $325K | $52.81M | $5.45M | $134.7M | $155.4M | $64.85M | -- |
| Financing Cash Flow | $174.7M | $29.45M | $13.82M | $614K | $53.06M | $7.60M | $139.6M | $159.8M | $67.24M | $153K |
| Net Change in Cash | $20.11M | $18.50M | -$32.58M | $6.79M | -$13.82M | $12.71M | $5.26M | -$40.56M | $53.46M | $1.47M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$20.26M | -$3.86M | -$9.08M | $22.09M | -$9.20M | -$10.20M | -$8.82M | -$10.34M |
| Depreciation & Amortization | $24K | $20K | $26K | $32K | $32K | $32K | $33K | $32K |
| Stock-Based Compensation | $3.32M | $2.42M | $1.12M | $1.46M | $1.67M | $834K | $712K | $751K |
| Change in Receivables | $240K | -$371K | $523K | -$62K | -$912K | $0 | $0 | $0 |
| Change in Payables | $2.12M | -$70K | -$42K | -$512K | $940K | -$132K | $290K | -$750K |
| Operating Cash Flow | -$17.16M | -$15.49M | -$22.10M | $14.24M | -$15.13M | -$16.76M | -$23.44M | -$407K |
| Capital Expenditure | -$121K | $0 | -$19K | -$24K | -$42K | $0 | $0 | $0 |
| Free Cash Flow | -$17.29M | -$15.49M | -$22.12M | $14.21M | -$15.18M | -$16.76M | -$23.44M | -$407K |
| Purchases of Investments | -$75.28M | -$145.8M | -$62.96M | -$11.55M | -$180.9M | -$17.51M | -$19.85M | -$40.90M |
| Investing Cash Flow | $3.51M | -$92.08M | -$5.38M | $21.22M | -$158.3M | $16.99M | $6.59M | -$6.70M |
| Common Stock Issued | $0 | $0 | $0 | $0 | $0 | $0 | $1.92M | $2.03M |
| Financing Cash Flow | $10.44M | $108.7M | $149K | $456K | $171.9M | $357K | $1.92M | $17.00M |
| Net Change in Cash | -$3.21M | $1.17M | -$27.33M | $35.92M | -$1.47M | $593K | -$14.93M | $9.89M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -16.8% | -159.3% | -902.5% | -- | -2121.7% | -81.9% | -643.4% | -626.4% | -579.1% | -- |
| Net Profit Margin | -8.5% | -140.9% | -854.8% | -- | -2076.4% | -78.6% | -611.6% | -613.0% | -474.7% | -- |
| Return on Equity (ROE) | -3.0% | -120.4% | -149.0% | -112.6% | -76.9% | -25.8% | -35.7% | -43.1% | -37.8% | -55.4% |
| Return on Assets (ROA) | -2.4% | -33.7% | -44.7% | -91.5% | -68.0% | -21.9% | -28.7% | -33.9% | -25.3% | -45.1% |
| Current Ratio | 5.22x | 2.42x | 3.41x | 5.95x | 9.59x | 9.19x | 11.57x | 12.05x | 9.13x | 7.52x |
| Quick Ratio | 5.11x | 2.34x | 3.32x | 5.68x | 9.14x | 8.91x | 11.35x | 11.94x | 9.06x | 7.44x |
| Debt to Equity | 0.01x | 0.09x | 0.06x | 0.04x | 0.04x | 0.04x | 0.04x | -- | -- | -- |
| Revenue Growth (YoY) | +153.5% | +298.2% | -- | -100.0% | -92.1% | +395.6% | +7.8% | +64.1% | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -324.8% | -- | -- | -- | -- | -- | -3592.4% | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -327.4% | -- | -- | -- | -- | -- | -6662.6% | -- | -- |
| 5Y Revenue / Share Growth | -75.9% | -34.9% | -79.9% | -100.0% | -- | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -- | -- | -- | -- | -116.8% | -130.9% | -138.8% | -159.3% |
| Net Profit Margin | -- | -- | -- | -- | -103.6% | -117.2% | -124.1% | -140.9% |
| Return on Equity (ROE) | -3.7% | 0.0% | -3.2% | -3.0% | -21.1% | -215.3% | -147.1% | -120.4% |
| Return on Assets (ROA) | -3.4% | 0.0% | -2.7% | -2.4% | -16.1% | -48.2% | -40.3% | -33.7% |
| Current Ratio | 12.89x | 13.99x | 6.65x | 5.22x | 4.44x | 1.64x | 2.05x | 2.42x |
| Quick Ratio | 12.64x | 13.70x | 6.49x | 5.11x | 4.37x | 1.59x | 1.95x | 2.34x |
| Debt to Equity | 0.01x | 0.01x | 0.01x | 0.01x | 0.02x | 0.16x | 0.11x | 0.09x |
| Revenue Growth (YoY) | -72.6% | +38.9% | -12.8% | -- | +57.6% | +12.8% | +62.8% | +2.7% |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -100.6% |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -100.6% |